Diabetes 51:591-598, 2002
© 2002 by the American Diabetes Association, Inc.
Human Skeletal Muscle Expresses a Glycogen-Targeting Subunit of PP1 That Is Identical to the Insulin-Sensitive Glycogen-Targeting Subunit GL of Liver
Shonagh Munro1,
Daniel J.R. Cuthbertson2,
Joan Cunningham3,
Mark Sales3, and
Patricia T.W. Cohen1
1 Medical Research Council Protein Phosphorylation Unit, School of Life Sciences,University of Dundee, Dundee, Scotland, U.K.
2 Clinical Investigation Unit, Ninewells Hospital Medical School, University of Dundee, Dundee, Scotland, U.K.
3 Department of Human Genetics (Cytogenetics), Ninewells Hospital Medical School, University of Dundee, Dundee, Scotland, U.K.
Insulin has been previously shown to regulate the expression of the hepatic glycogen-targeting subunit, GL, of protein phosphatase 1 (PP1) and is believed to control the activity of the PP1-GL complex by modulation of the level of phosphorylase a, which allosterically inhibits the activity of PP1-GL. These mechanisms contribute to the ability of insulin to increase hepatic glycogen synthesis. Human GL shows >88% amino acid identity to its rat and mouse homologs, with complete conservation of the phosphorylase a binding site. GL is highly expressed in the liver and present at appreciable levels in heart tissue of all three species. Surprisingly, GL is highly expressed in human skeletal muscle while only being detected at very low levels in rat, mouse, and rabbit skeletal muscle. The amino acid sequence of GL predicted from the cDNA is identical in human liver and skeletal muscle and encoded by a gene on chromosome 8 at p23.1. The species-specific difference in the level of expression of GL mRNA and protein in skeletal muscle has important implications for understanding the mechanisms by which insulin regulates glycogen synthesis in human skeletal muscle and for questions regarding whether rodents are appropriate models for this purpose.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Greenberg, A. M. Danos, and M. J. Brady
Central Role for Protein Targeting to Glycogen in the Maintenance of Cellular Glycogen Stores in 3T3-L1 Adipocytes
Mol. Cell. Biol.,
January 1, 2006;
26(1):
334 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Green, S. Aiston, C. C. Greenberg, S. Freeman, S. M. Poucher, M. J. Brady, and L. Agius
The Glycogenic Action of Protein Targeting to Glycogen in Hepatocytes Involves Multiple Mechanisms Including Phosphorylase Inactivation and Glycogen Synthase Translocation
J. Biol. Chem.,
November 5, 2004;
279(45):
46474 - 46482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Pezzolesi, M. Nam, T. Nagase, T. Klupa, J. S. Dunn, W. M. Mlynarski, S. S. Rich, J. H. Warram, and A. S. Krolewski
Examination of Candidate Chromosomal Regions for Type 2 Diabetes Reveals a Susceptibility Locus on Human Chromosome 8p23.1
Diabetes,
February 1, 2004;
53(2):
486 - 491.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. C. Greenberg, K. N. Meredith, L. Yan, and M. J. Brady
Protein Targeting to Glycogen Overexpression Results in the Specific Enhancement of Glycogen Storage in 3T3-L1 Adipocytes
J. Biol. Chem.,
August 15, 2003;
278(33):
30835 - 30842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|